Search Results

Your search for "Infectious Diseases" returned the following 6 expert(s):

BROWN, EARL »


EARL BROWN

Emeritus professor
Faculty of Medicine
Biochemistry, Microbiology and Immunology

Contact information:

Office: 16132247533
Office: 6135625800x8299
Cell: 16137168026
E-mail:

Preferred method of contact:

E-mail

Research information:

Performed genetic studies of RNA viruses with a focus on evolution of virulence in influenza virus, reovirus replication and cancer treatment, and hepatitis C immune evasion. The work focused on understands viral replication so that virus infection can both be prevented and alternatively be applied as therapy to treat diseases. He is a founding member of the Canadian Oncolytic Virus Consortium that is developing viruses as novel tumor therapeutics. He is also the founding Executive Director of the University of Ottawa for Emerging Pathogens Research Centre (EPRC). Dr. Brown is an internationally recognized influenza researcher who sits on various committees and institutional groups (CIHR workshop on influenza research priorities 2005; CIHR Pandemic Preparedness Strategic Research Initiative Task group; Organizing and program committee Chair of the 2008 of Canadian Pandemic Preparedness Meeting ; Pandemic Vaccine Working Group of the Public Health Agency of Canada; ) dealing with influenza pandemic preparedness.

Area(s) of expertise:

(View other experts in this field)

Language preference:

English only

CAMPBELL-VALOIS, François-Xavier »


Yes
Associate professor
Faculty of Science
Chemistry

Contact information:

Office: 3976
Cell: 819-968-3646
E-mail:
Website

Preferred method of contact:

Cell Telephone

Research information:

My research group is interested in understanding the interplay established between bacteria and their host during infection.

We are currently focusing on the enteropathogen Shigella flexneri, which use a Type Three Secretion Apparatus (T3SA) to inject some of its proteins inside human intestinal cells. Our main interests are:

  1. T3SA functioning and regulation;
  2. bacterial strategies for hijacking the biological processes of the host;
  3. bacterial and host adaptation at play during infection. Our long-term objective is to identify novel therapeutic avenues to treat infectious diseases.

Keywords: gastrointestinal infections caused by bacteria of the Shigella genus and other Escherichia coli.

Area(s) of expertise:

(View other experts in this field)

Language preference:

English and French

CRANDALL, Kirsten »


PhD student
Faculty of Science
Biology

Contact information:

E-mail:

Preferred method of contact:

E-mail

Research information:

My research focuses on the ecological and environmental factors affecting ticks, vertebrate hosts, and pathogens (e.g., bacteria, virus, etc) of the tick-borne disease system in Canada. I use a wide variety of methods including meta-analyses, field surveys and experiments, genetic analyses, and remote sensing analyses.

Area(s) of expertise:

(View other experts in this field)

Language preference:

English and French

LANGLOIS, Marc-André »


Canada Research Chair in Molecular Virology and Intrinsic Immunity
Assistant professor
Faculty of Medicine
Biochemistry, Microbiology and Immunology

Contact information:

E-mail:
Website

Preferred method of contact:

E-mail

Research information:

HIV, Retroviruses and Immunity

Area(s) of expertise:

(View other experts in this field)

Language preference:

English and French

NICKERSON, Jason »


Adjunct Professor
Faculty of Law, Common Law Section

Contact information:

E-mail:

Preferred method of contact:

E-mail

Research information:

Dr. Jason Nickerson, RRT, PhD is the Humanitarian Representative to Canada for Doctors Without Borders/Médecins Sans Frontières (MSF), based in Ottawa. Jason is appointed as a Clinical Scientist at the Bruyère Research Institute in Ottawa and as an Adjunct Professor of Common Law at the University of Ottawa’s Centre for Health Law, Policy and Ethics. He leads MSF’s humanitarian diplomacy in Canada and provides advice on humanitarian operations, medical advocacy and policy, and access to medicines to MSF’s operations in more than 70 countries affected by crises. Jason has over 10 years’ clinical experience as a respiratory therapist working in adult critical care and anesthesia and has worked extensively in global public health response in Canada and internationally during armed conflicts, disease epidemics, and sudden onset disasters. Jason is a graduate of Dalhousie University’s Bachelor of Health Sciences in Respiratory Therapy program, specializing in anesthesia. Following this, he completed a master’s degree at the University of British Columbia studying the education of health professionals who provide community-based HIV care, and a PhD in population health at the University of Ottawa where he focused on the methodologies for conducting assessments of severely disrupted health systems during acute and protracted emergencies. His research has been published in high-impact medical journals including The Lancet, the Canadian Medical Association Journal, PLOS Medicine, and Health Policy and Planning, among others. He has appeared as a witness before the Canadian Parliament’s Standing Committees on Health, Finance, and International Trade and published opinion pieces in The Star, iPolitics, and The Conversation, and has been widely quoted in international news outlets on a variety of global health and health policy issues including COVID-19, access to pain medicines for safe anesthesia and palliative care, access to affordable medicines, science policy, and humanitarian assistance in natural disasters, armed conflicts, refugee crises, and disease epidemics such as Ebola.

Area(s) of expertise:

(View other experts in this field)

Language preference:

English only

TYNDALL, Mark »


Senior Scientist, Ottawa Hospital Research Institute
Faculty of Medicine

Contact information:

Office: 613-737-8899 (73353)
E-mail:

Preferred method s of contact:

E-mail, Office Telephone

Research information:

My main research interests include the prevention, care and treatment of HIV among people who use drugs.  The methods include cohort studies and community-based research approaches to capacity building and advocacy.

Area(s) of expertise:

(View other experts in this field)

Language preference:

English only